Is Microdosing Placebo and Does that Matter?

Microdosing is often marketed as a real pharmacological boost, but placebo effects may explain many reported benefits. The article frames microdosing as taking tiny sub-perceptual doses (commonly LSD or psilocybin) intended to avoid noticeable “trip” effects, and then contrasts the popularity of claims like improved mood, focus, creativity, and relief from anxiety or depression with the limited amount of rigorous large-scale placebo-controlled evidence. Research discussed includes self-report based evidence and a placebo-controlled “self-blinding” design where participants could not reliably tell whether they received the psychedelic or a placebo; in that framing, perceived benefits tended to drop when expectation was removed. The piece argues that even if benefits are placebo-driven, they can still produce real subjective and health-related changes, but the placebo-or-not distinction matters for safety, ethical marketing, and the risk that people may self-treat serious conditions with expectation rather than proven care.